Human Plasma Samples

Central BioHub offers Human Plasma Samples in different qualities. So you can clearly see, if a biospecimen is for instance haemolytic or in perfect condition. We offer ACD, Citrate, CPD, CPDA, EDTA, K2 EDTA, K3 EDTA, Na EDTA, Heparin, NaHep, LiHep, K Oxalate and NaF Plasma. To meet your Research and Developement (R&D) needs use further filtering and customize your search for example by laboratory parameters, disease in clear name or ICD-10 code, donor specifications, quantity and price. If you do not find the sample you are looking for, please contact us.

Available filters
-
-
-
5,000 Products

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
Addel
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
Gender:
Female
Age:
59 Years
BMI:
24.8 kg/m²
Weight:
70 kg
Height:
168 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Addel
  • Aminoven
  • Cernevit
  • L-thyroxine
  • Meronem
  • Pantozol
  • bisoprolol
  • lercanidipine
  • metoclopramide
  • potassium
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 283 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.2 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 216.1 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 183 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 61 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 49 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 10.5 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 41 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 32 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308237
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C24.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
Fenistil
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
78 Years
BMI:
24.3 kg/m²
Weight:
67 kg
Height:
166 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Fenistil (Fenistil dry)
  • L-thyroxine (Dosages: 25not specified)
  • Ramipril (Dosages: 5not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25not specified)
  • pantoprazole (Dosages: 40not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 299 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 214 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 12.02 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 0.8 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual:
Quant: 164 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual:
Quant: 92 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 235 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 110 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 37 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 13.9 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual:
Quant: 703 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308307
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K43.2

Donor:
Gender: Male Age: 52
Medication:
Enbrel
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Male
Age:
52 Years
BMI:
28.1 kg/m²
Weight:
91 kg
Height:
180 cm
Sample:
Matrix:
EDTA plasma
Condition:
hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Medication:
  • Enbrel
  • Metoprolol (Dosages: 47not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 78 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 39 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.37 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 16.6 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 256 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 88 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 43 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 47 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 14.3 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 22 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308143
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 75
Medication:
Vitalux
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
75 Years
BMI:
27.2 kg/m²
Weight:
90 kg
Height:
182 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Medication:
  • Vitalux
  • metformin
  • salbutamol
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 191 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 58 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 8.35 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 29.6 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 373 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 131 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 241 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 99 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 40 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 12.9 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 89 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307960
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K86.1

Donor:
Gender: Female Age: 34
Medication:
Novaminsulfon
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Female
Age:
34 Years
BMI:
20.9 kg/m²
Weight:
64 kg
Height:
175 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Medication:
  • Novaminsulfon
  • Pantozol
  • Panzytrat
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 72 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 99 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.54 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 17.9 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 38 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 17 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 18 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 25 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 14.2 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 77 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308035
0.3 mL ($12.94)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Male Age: 69
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Fenistil
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Male
Age:
69 Years
BMI:
24 kg/m²
Weight:
76 kg
Height:
178 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Fenistil
  • Metohexal
  • Pantozol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 314 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 20.9 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 993.3 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 82 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 114 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 129 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 104 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 43 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 12.9 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 21 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 9 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308259
0.5 mL ($21.56)
Available ($225.00)

Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Hemogl... - C25.2

Donor:
Gender: Male Age: 82
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
Sortis
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
Gender:
Male
Age:
82 Years
BMI:
25.3 kg/m²
Weight:
73 kg
Height:
170 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
  • Sortis
  • amlodipine
Therapy:
  • transplant
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 75 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.5 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 407.8 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 49 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 24 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 31 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 14.7 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 22 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 12 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308273
0.5 mL ($21.56)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - D50.9

Donor:
Gender: Female Age: 58 Ethnic group: European/Caucasian
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
58 Years
Ethnic group:
European/Caucasian
BMI:
23 kg/m²
Weight:
68 kg
Height:
172 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Medication:
  • Metex (Dosages: 17.5mg/week)
  • Orencia (Dosages: 25mg/week, active agent: abatacept)
  • Tardyferon
  • escitalopram (Dosages: 10mg/day)
  • folic acid (Dosages: 5mg/week)
  • rosuvastatin (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: > 500.00 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: > 500.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.71 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 4.1 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 21 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 21 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 16 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292278
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - I10.90

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Brimica
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
65.3 kg
Height:
154 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Brimica
  • Ibuflam (Dosages: 800mg/day, active agent: ibuprofen)
  • Quensyl (active agent: hydroxychloroquine)
  • Tevanate (Dosages: 70mg/week)
  • Vigantoletten (Dosages: 1000IU/day)
  • leflunomide (Dosages: 10mg/day)
  • pantoprazole (Dosages: 20mg/day)
  • salbutamol (as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.86 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 7.1 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 38 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 11 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295903
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - C18.6

Donor:
Gender: Male Age: 66 Ethnic group: European/Caucasian
Diagnosed disease:
C18.6 - Malignant neoplasm of descending colon
Medication:
Hygroton
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Male
Age:
66 Years
Ethnic group:
European/Caucasian
BMI:
34 kg/m²
Weight:
104 kg
Height:
176 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of descending colon [C18.6]
Medication:
  • Hygroton (Dosages: 25mg/day, active agent: chlorthalidone)
  • Metex (Dosages: 125mg/week)
  • Prednisolon (Dosages: 2mg/day)
  • Simvabeta (Dosages: 10mg/day)
  • amlodipine (Dosages: 5mg/day)
  • bisoprolol (Dosages: 5mg/day)
  • hydroxychloroquine (Dosages: 400/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: < 8.00 IU/mL
Source: this donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 27.2 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 34.37 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 29 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292431
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E11.90

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Humalog
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
70 kg
Height:
164 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • E11.90
Medication:
  • Humalog (active agent: insulin lispro)
  • Lantus (active agent: insulin glargin)
  • Metex (Dosages: 20mg/week)
  • Orencia (Dosages: 750mg/4 weeks, active agent: abatacept)
  • Prednisolon (Dosages: 1mg, as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: 33 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 4.71 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.1 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 35 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: positive
Quant: 32 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295179
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - M05.80

Donor:
Gender: Female Age: 31 Ethnic group: European/Caucasian
Medication:
Ferro Sanol
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
31 Years
Ethnic group:
European/Caucasian
BMI:
22 kg/m²
Weight:
70 kg
Height:
178 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Medication:
  • Ferro Sanol (daily)
  • Metex (Dosages: 15mg/week)
  • Prednisolon (Dosages: 7.5mg/day)
  • Vigantoletten (Dosages: 1000IU/day)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 202 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: 205 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.3 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 17 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 62 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 73 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292230
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - M05.80

Donor:
Gender: Female Age: 49 Ethnic group: European/Caucasian
Medication:
Folsan
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
49 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
70 kg
Height:
165 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Medication:
  • Folsan (Dosages: 5mg/week, active agent: folic acid)
  • Metex (Dosages: 17.5mg/week)
  • Orencia (Dosages: 125mg/week, active agent: abatacept)
  • Prednisolon (as needed)
  • Vigantoletten (Dosages: 1000IU/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: 11 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.06 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 35 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 57 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 64 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295897
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - E07.9

Donor:
Gender: Female Age: 63 Ethnic group: European/Caucasian
Diagnosed disease:
E07.9 - Disorder of thyroid, unspecified
Medication:
Prednisolon
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
63 Years
Ethnic group:
European/Caucasian
BMI:
46 kg/m²
Weight:
116 kg
Height:
159 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
slightly turbid
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Disorder of thyroid, unspecified [E07.9]
Medication:
  • Prednisolon (Dosages: 8mg/day)
  • Vigantoletten (Dosages: 1000IU/day)
  • leflunomide (Dosages: 10mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.2 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 4.64 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 29 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 12 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: negative
Quant: 40 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: 10 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH233874
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 70
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
omeprazole
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Male
Age:
70 Years
BMI:
23.7 kg/m²
Weight:
70 kg
Height:
172 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
  • arterial hypertension
  • diarrhea
  • normochromic anemia
  • pancreas carcinoma - ductal. Adenocarcinoma (not specified)
Medication:
  • omeprazole (Dosages: 40not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 75 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 6 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 0.37 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 27 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual:
Quant: 25 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 18 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 21 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 34 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 13.5 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual:
Quant: 16 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308309
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Glutamic oxaloacetic transaminase (GO... - K86.0

Donor:
Gender: Male Age: 51
Medication:
Kreon
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase Pancreatic Amylase ...
Donor:
Gender:
Male
Age:
51 Years
BMI:
30 kg/m²
Weight:
92 kg
Height:
175 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Medication:
  • Kreon
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 99 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.7 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 8.9 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 30 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 18 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 8 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 40 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 14.5 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 28 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 32 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308281
0.5 mL ($21.56)
Available ($225.00)

Human K2EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0

Donor:
Gender: Female Age: 40 Ethnic group: European/Caucasian
Diagnosed disease:
E89.0 - Postprocedural hypothyroidism
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH)
Donor:
Gender:
Female
Age:
40 Years
Ethnic group:
European/Caucasian
BMI:
24.51 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
70 kg
Height:
169 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • Postprocedural hypothyroidism [E89.0]
Medication:
  • L-thyroxine (Dosages: 100not specified)
  • calcium (Dosages: 500mg)
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 144 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: positive
Quant: 2.34 IU/L
Source: previous donation
< 1.22 IU/L
Method: not specified
System: Cobas Modular Roche
Thyrotropin (TSH)
Qual: negative
Quant: 3.53 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH330562
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E11.40

Donor:
Gender: Male Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Aldactone
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Male
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
125 kg
Height:
196 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.40
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • Aldactone (Dosages: 25not specified, active agent: spironolactone)
  • Atozet
  • Hygroton (Dosages: 25not specified, active agent: chlorthalidone)
  • Jardiance (Dosages: 10mg)
  • L-Thyrox (Dosages: 150not specified)
  • allopurinol (Dosages: 100not specified)
  • amlodipine (Dosages: 5mg)
  • insulin
  • metformin
  • no incretin mimetics
  • valsartan (Dosages: 80mg)
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: positive
Quant: 10.1 %
Source: this donation
4.00 - 6.00 %
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344377
1 mL ($43.13)
Available ($225.00)

Human K2EDTA plasma - C73

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroglobulin (aTg / TAK)
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
35 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
115 kg
Height:
182 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • C73
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 150not specified)
  • Ramipril (Dosages: 10mg)
  • amlodipine (Dosages: 5mg)
  • atorvastatin (Dosages: 20mg)
  • pramipexole (Dosages: 0.7mg)
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 0.09 kIU/L
Source: previous donation
< 115.00 kIU/L
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344249
4.2 mL ($181.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E06.3

Donor:
Gender: Female Age: 20 Ethnic group: European/Caucasian
Diagnosed disease:
E06.3 - Autoimmune thyroiditis
Medication:
Amgevita
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
20 Years
Ethnic group:
European/Caucasian
BMI:
18 kg/m²
Weight:
58 kg
Height:
178 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • rheumatoid arthritis [E06.3]
Medication:
  • Amgevita (Dosages: 40mg/2 weeks)
  • L-thyroxine (Dosages: 50µg/day)
  • Prednisolon (Dosages: 5mg, as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 214 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: 284 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.94 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 12 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH240764
0.5 mL ($21.56)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E66.92

Donor:
Gender: Male Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
E66.92
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Male
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
40 kg/m²
Weight:
130 kg
Height:
180 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 8 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 8 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 8 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 8 (information given at the time of donation)
Diseases:
  • E66.92
Medication:
  • Metex (Dosages: 10mg/week)
  • Prednisolon (Dosages: 1mg/day)
  • Ramipril (Dosages: 5mg/day)
  • bisoprolol (Dosages: 5mg/day)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 316 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 25.43 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 35 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 265 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303758
1 mL ($43.13)
Available ($225.00)

Human K2EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0

Donor:
Gender: Female Age: 52 Ethnic group: European/Caucasian
Medication:
Forsteo
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb)
Donor:
Gender:
Female
Age:
52 Years
Ethnic group:
European/Caucasian
BMI:
25 kg/m²
Weight:
71 kg
Height:
170 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Medication:
  • Forsteo (acitve agent: teriparatide)
  • Tianeurax (acitve agent: tianeptine)
  • doxepin
  • thiamazole (Dosages: 2.5mg/2 days)
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: > 600.00 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: positive
Quant: 17.5 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH322715
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - I10.90

Donor:
Gender: Male Age: 57 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Male
Age:
57 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
96 kg
Height:
181 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 10 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 10 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 10 (information given at the time of donation)
Diseases:
  • I10.90
Medication:
  • Metex (Dosages: 15mg/week)
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • Ramipril (Dosages: 10mg/day)
  • alendronic acid (Dosages: 70mg/week)
  • amlodipine (Dosages: 10mg/day)
  • folic acid (Dosages: 5mg/week)
  • simvastatine (Dosages: 40mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: > 500.00 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.93 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 25 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 99 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303760
1 mL ($43.13)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - K42.9

Donor:
Gender: Male Age: 78
Diagnosed disease:
K42.9 - Umbilical hernia without obstruction or gangrene
Medication:
Pantozol
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb)
Donor:
Gender:
Male
Age:
78 Years
BMI:
27 kg/m²
Weight:
78 kg
Height:
170 cm
Sample:
Matrix:
EDTA plasma
Condition:
hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Umbilical hernia without obstruction or gangrene [K42.9]
Medication:
  • Pantozol (Dosages: 40mg)
  • RamiLich
  • lactulose
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 98 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 0.19 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 8.1 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual:
Quant: 21 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual:
Quant: 102 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 11 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 22 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 40 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 14.3 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308314
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K40.0

Donor:
Gender: Male Age: 60
Diagnosed disease:
K40.0 - Bilateral inguinal hernia, with obstruction, without gangrene
Medication:
EnaHEXAL
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase
Donor:
Gender:
Male
Age:
60 Years
BMI:
31.1 kg/m²
Weight:
92 kg
Height:
172 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Bilateral inguinal hernia, with obstruction, without gangrene [K40.0]
Medication:
  • EnaHEXAL
  • Simva (Dosages: 20mg)
  • bisoprolol (Dosages: 5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 71 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 30 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 1.39 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 4.9 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual:
Quant: 56 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 46 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 34 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 16 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual:
Quant: 41 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308315
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - K86.1

Donor:
Gender: Male Age: 62
Medication:
Kreon
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Male
Age:
62 Years
BMI:
22.5 kg/m²
Weight:
73 kg
Height:
180 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Medication:
  • Kreon
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 82 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 7 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 0.49 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 4.3 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual:
Quant: 28 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 44 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 13.9 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual:
Quant: 13 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308311
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Male Age: 51
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
Medication:
Euthyrox
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Male
Age:
51 Years
BMI:
44.8 kg/m²
Weight:
142 kg
Height:
178 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
  • Euthyrox
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 681 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 12.3 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1000 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 1028 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 180 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 97 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 81 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 32 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 11.3 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 65 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 22 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308248
0.5 mL ($21.56)
Available ($225.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - J45.9

Donor:
Gender: Female Age: 52 Ethnic group: European/Caucasian
Diagnosed disease:
J45.9 - Asthma, unspecified
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
52 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
94 kg
Height:
177 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Asthma, unspecified [J45.9]
Medication:
  • Metex (Dosages: 17.5mg/week)
  • folic acid (Dosages: 5mg/week)
  • sulfasalazine (Dosages: 1000mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: < 8.00 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.4 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 4.21 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 25 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292294
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - K76.0

Donor:
Gender: Female Age: 53 Ethnic group: European/Caucasian
Diagnosed disease:
K76.0 - Fatty (change of) liver, not elsewhere classified
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
53 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
78 kg
Height:
156 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Fatty (change of) liver, not elsewhere classified [K76.0]
Medication:
  • Metex (Dosages: 7.5mg/week)
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • folic acid (Dosages: 5mg/week)
  • ibuprofen (Dosages: 800mg, as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 197 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: 297 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.3 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: < 0.60 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 31 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292324
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - J30.1

Donor:
Gender: Female Age: 61 Ethnic group: European/Caucasian
Diagnosed disease:
J30.1 - Allergic rhinitis due to pollen
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
61 Years
Ethnic group:
European/Caucasian
BMI:
25 kg/m²
Weight:
78 kg
Height:
178 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Allergic rhinitis due to pollen [J30.1]
Medication:
  • Metex (Dosages: 15mg/week)
  • folic acid (Dosages: 5mg/week)
  • hydroxychloroquine (Dosages: 400mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 139 IU/mL
Source: this donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: 101 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.8 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 9 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 35 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 33 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292438
1 mL ($43.13)
Available ($225.00)